Holmium iron borate: high-resolution spectroscopy and crystal-field parameters

High-resolution transmission spectra of HoFe3(BO3)4 single crystals were measured in broad spectral (5000-23000 cm−1) and temperature (1.7-300 K) ranges. Crystal-field energies of the Ho3+ ions were determined for a paramagnetic and easy-axis antiferromagnetic phases of the compound. On the basis of these data and of preliminary crystal-field calculations in the frame of the exchange-charge model, crystal-field parameters were found. A parameter of the isotropic Ho-Fe exchange interaction was estimated

High-resolution optical spectroscopy, magnetic properties, and single-crystal neutron diffraction of multiferroic HoFe3(BO3)4: Magnetic structure

The magnetic structure is usually determined by the neutron diffraction measurements. However, in the case of complex multisublattice magnetics, this method fails to give an unambiguous result. Here, on the example of multiferroic HoFe3(BO3)4, we show that in the case of rare-earth (RE) compounds the right magnetic structure can be determined by additionally using optical spectroscopy and a theoretical analysis based on spectroscopic data. HoFe3(BO3)4 demonstrates a series of phase transitions and interesting magnetic and magnetoelectric properties. The available information on the magnetic structure of the compound, necessary for understanding and utilizing these properties, is contradictory. To resolve the existing ambiguities, we apply a combined approach. The high-resolution spectroscopy data deliver a set of the Ho3+ crystal-field (CF) levels in the paramagnetic and both easy-plane and easy-axis magnetic phases. These data are used to determine CF and Ho3+-Fe3+ exchange parameters and, then, to calculate the temperature dependencies of the magnetic susceptibility tensor of HoFe3(BO3)4. Based on these calculations, we suggest an easy-plane antiferromagnetic structure with a collinear arrangement of the Fe spins along the a axis and induced noncolinear moments of magnetically nonequivalent Ho ions. The suggested structure is further confirmed by single-crystal elastic neutron scattering experiments. We argue that specific features of the magnetic properties of RE iron borates isostructural to HoFe3(BO3)4 are governed by the energy patterns and the symmetry properties of the wave functions of the lower CF levels of the RE ground multiplet in the crystal field of the C2 symmetry

Novel Copper-Containing Cytotoxic Agents Based on 2-Thioxoimidazolones

A series of 73 ligands and 73 of their Cu+2 and Cu+1 copper complexes with different geometries, oxidation states of the metal, and redox activities were synthesized and characterized. The aim of the study was to establish the structure-activity relationship within a series of analogues with different substituents at the N(3) position, which govern the redox potentials of the Cu+2/Cu+1 redox couples, ROS generation ability, and intracellular accumulation. Possible cytotoxicity mechanisms, such as DNA damage, DNA intercalation, telomerase inhibition, and apoptosis induction, have been investigated. ROS formation in MCF-7 cells and three-dimensional (3D) spheroids was proven using the Pt-nanoelectrode. Drug accumulation and ROS formation at 40-60 μm spheroid depths were found to be the key factors for the drug efficacy in the 3D tumor model, governed by the Cu+2/Cu+1 redox potential. A nontoxic in vivo single-dose evaluation for two binuclear mixed-valence Cu+1/Cu+2 redox-active coordination compounds, 72k and 61k, was conducted.

PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation

Prostate cancer is one of the most commonly diagnosed men's cancers and remains one of the leading causes of cancer death. The development of approaches to the treatment of this oncological disease is an ongoing process. In this work, we have carried out the selection of ligands for the creation of conjugates based on the drug docetaxel and synthesized a series of three docetaxel conjugates. In vitro cytotoxicity of these molecules was evaluated using the MTT assay. Based on the assay results, we selected the conjugate which showed cytotoxic potential close to unmodified docetaxel. At the same time, the molar solubility of the resulting compound increased up to 20 times in comparison with the drug itself. In vivo evaluation on 22Rv1 (PSMA+) xenograft model demonstrated a good potency of the synthesized conjugate to inhibit tumor growth: the inhibition turned out to be more than 80% at a dose of 30 mg/kg. Pharmacokinetic parameters of conjugate distribution were analyzed. Also, it was found that PSMA-targeted docetaxel conjugate is less toxic than docetaxel itself, the decrease of molar acute toxicity in comparison with free docetaxel was up to 20%. Obtained conjugate PSMA-DOC is a good candidate for further expanded preclinical trials because of high antitumor activity, fewer side toxic effects and better solubility. © 2021 Elsevier Masson SA

Synthesis, Characterization, and Preclinical Evaluation of a Small-Molecule Prostate-Specific Membrane Antigen-Targeted Monomethyl Auristatin e Conjugate

Prostate cancer is the second most common type of cancer among men. Its main method of treatment is chemotherapy, which has a wide range of side effects. One of the solutions to this challenge is targeted delivery to prostate cancer cells. Here we synthesized a novel small-molecule PSMA-targeted conjugate based on the monomethyl auristatin E. Its structure and conformational properties were investigated by NMR spectroscopy. Cytotoxicity, intracellular reactive oxygen species induction, and stability under liver microsomes and P450-cytochrome species were investigated for this conjugate. The conjugate demonstrated 77-85% tumor growth inhibition levels on 22Rv1 (PSMA (+)) xenografts, compared with a 37% inhibition level on PC-3 (PSMA (-)) xenografts, in a single dose of 0.3 mg/kg and a sufficiently high therapeutic index of 21. Acute, chronic, and subchronic toxicities and pharmacokinetics have shown that the synthesized conjugate is a promising potential agent for the chemotherapy of prostate cancer. © 2021 American Chemical Society

Synthesis and Biological Evaluation of PSMA Ligands with Aromatic Residues and Fluorescent Conjugates Based on Them

Prostate-specific membrane antigen (PSMA), also known as glutamate carboxypeptidase II (GCPII), is a suitable target for specific delivery of antitumor drugs and diagnostic agents due to its overexpression in prostate cancer cells. In the current work, we describe the design, synthesis, and biological evaluation of novel low-molecular PSMA ligands and conjugates with fluorescent dyes FAM-5, SulfoCy5, and SulfoCy7. In vitro evaluation of synthesized PSMA ligands on the activity of PSMA shows that the addition of aromatic amino acids into a linker structure leads to a significant increase in inhibition. The conjugates of the most potent ligand with FAM-5 as well as SulfoCy5 demonstrated high affinities to PSMA-expressing tumor cells in vitro. In vivo biodistribution in 22Rv1 xenografts in Balb/c nude mice of PSMA-SulfoCy5 and PSMA-SulfoCy7 conjugates with a novel PSMA ligand demonstrated good visualization of PSMA-expressing tumors. Also, the conjugate PSMA-SulfoCy7 demonstrated the absence of any explicit toxicity up to 87.9 mg/kg. © 2021 American Chemical Society. All rights reserved